JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 31 No. 10 1654-1658
© 1990 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fujiwara, T.
Right arrow Articles by Ido, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fujiwara, T.
Right arrow Articles by Ido, T.

N-[18F]Fluoroacetyl-D-glucosamine: A Potential Agent for Cancer Diagnosis

Takehiko Fujiwara, Kazuo Kubota, Tachio Sato, Taiju Matsuzawa, Masao Tada, Ren Iwata, Masatoshi Itoh, Jun Hatazawa, Kazunori Sato, Hiroshi Fukuda and Tatsuo Ido

Department of Radiology and Nuclear Medicine, Research Institute for Tuberculosis and Cancer, Tohoku University
Department of Pharmacology, Research Institute for Tuberculosis and Cancer, Tohoku University
Cyclotron and Radioisotope Center, Tohoku University
Radioisotope Laboratory Section, Research Institute for Tuberculosis and Cancer, Tohoku University, Seiryocho, Japan
Division of Clinical Research, National Institute of Radiological Science, Chiba, Japan

Correspondence: For reprints contact: Kazuo Kubota, MD, PhD, Department of Radiology and Nuclear Medicine, Research Institute for Tuberculosis and Cancer, Tohoku University, 4-1 Seiryocho, Aoba-Ku, Sendai 980, Japan.

ABSTRACT

Positron labeled substrates such as sugars, amino acids, and nucleosides have been investigated for the in-vivo evaluation of biochemical processes in cancerous tissue. Hexosamines are obligatory structural components of many biologically important macromolecules, including membrane glycoproteins and mucopolysaccharide. We evaluated a new synthesized pharmaceutical, N-[18F]fluoroacetyl-D-glucosamine (18F-FAG), which is a structural analog of N-acetyl-D-glucosamine. C3H/HeMsNRS mice bearing spontaneous hepatomas were used for the tissue distribution study. At 60 min after injection, high uptakes were found in tumor (5.16, mean value of %dose/g), liver (3.71), and kidney (3.27). The tumor uptake of 18F-FAG showed the highest value in all tissues. In the PET study, VX-2 carcinoma of the rabbit was clearly visualized. Our preliminary results suggest that 18F-FAG has potential as a new agent for tumor imaging.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1990 by the Society of Nuclear Medicine.